Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

Amy S. Paller, Elaine C. Siegfried, Diamant Thaçi, Andreas Wollenberg, Michael J. Cork, Peter D. Arkwright, Melinda Gooderham, Lisa A. Beck, Mark Boguniewicz, Lawrence Sher, Jamie Weisman, John T. O'Malley, Naimish Patel, Megan Hardin, Neil M.H. Graham, Marcella Ruddy, Xian Sun, John D. Davis, Mohamed A. Kamal, Faisal A. KhokharDavid M. Weinreich, George D. Yancopoulos, Bethany Beazley, Ashish Bansal, Brad Shumel*

*Korrespondierende/r Autor/-in für diese Arbeit
5 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie